David A. Giljohann

Vorstandsvorsitzender bei EVOQ Therapeutics, Inc.

43 Jahre

Health Technology

Consumer Services

Aktive Positionen von David A. Giljohann

Unternehmen	Position	Beginn	Ende
EVOQ Therapeutics, Inc. EVOQ Therapeutics, Inc. BiotechnologyHealth Technology EVOQ Therapeutics LLC operates as a biopharmaceutical company, which engages in developing new vaccine technologies for improving outcomes for cancer patients. The company was founded by William Brinkerhoff, James Moon, and Anna Schwendeman in 2016 and is headquartered in Ann Arbor, MI.	Vorstandsvorsitzender	09.01.2023	-

Unternehmen	Position	Beginn	Ende
EXICURE, INC.	Direktor/Vorstandsmitglied	01.03.2014	10.12.2021
	Vorstandsvorsitzender	01.11.2013	10.12.2021
	Geschäftsführer	01.07.2012	01.10.2013
	Technik-/Wissenschafts-/F&E-Leiter	10.12.2021	31.01.2022
	Finanzdirektor/CFO	30.09.2020	13.05.2021
	Unternehmenssekretär	30.09.2020	10.12.2021
Aurasense LLC	Technik-/Wissenschafts-/F&E-Leiter	-	01.01.2009
Exicure Operating Co. Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.	Direktor/Vorstandsmitglied	01.03.2014	-
	Vorstandsvorsitzender	01.11.2013	-
	Geschäftsführer	30.07.2012	01.10.2013
	Corporate Officer/Principal	01.01.2011	01.06.2012

Northwestern University

Doctorate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Health Technology	4
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
EXICURE, INC.	Health Technology

Private Unternehmen	3
Exicure Operating Co. Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.	Health Technology
Aurasense LLC
EVOQ Therapeutics, Inc. EVOQ Therapeutics, Inc. BiotechnologyHealth Technology EVOQ Therapeutics LLC operates as a biopharmaceutical company, which engages in developing new vaccine technologies for improving outcomes for cancer patients. The company was founded by William Brinkerhoff, James Moon, and Anna Schwendeman in 2016 and is headquartered in Ann Arbor, MI.	Health Technology